{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-015876","form_type":"8-K","ticker":"STXS","cik":"0001289340","company_name":"Stereotaxis, Inc.","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.282684+00:00","generated_at":"2026-06-15T08:25:13.880847+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Stereotaxis Q1 revenue $6.5M, net loss $5.3M; reiterates double-digit growth outlook","bullets":["Revenue $6.5M vs $7.0M prior year; excluding catheter royalties, essentially flat.","Net loss $5.3M vs $4.1M; adjusted net loss (excl stock comp) $2.7M vs $1.6M.","Gross margin 59%; recurring revenue gross margin 79%, system margin 7% on low volumes.","Cash $26.8M with no debt; year-end cash expected $22-24M; sees double-digit revenue growth in 2023.","Orders received for two Genesis systems; expects increase in system orders vs 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-015876","json":"https://secwatch.observer/filing/0001493152-23-015876.json","markdown":"https://secwatch.observer/filing/0001493152-23-015876.md","text":"https://secwatch.observer/filing/0001493152-23-015876.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289340/000149315223015876/0001493152-23-015876-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289340/000149315223015876/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T08:25:13.880847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"26db11e811e525bd39bb6175cd5d26de4e8cd2f7","claim":"Stereotaxis, Inc. reported the first quarter ended March 31, 2023 results: revenue $6.5 million, net income ($5.3) million. Guidance reaffirmed.","evidence_excerpt":"on May 19-21 and sharing meaningful updates on our innovation strategy at the conference.” 2023 First Quarter Financial Results Revenue for the first quarter of 2023 totaled $6.5 million compared to $7.0 million in the prior year first quarter. Revenue in these quarters were equivalent excluding catheter royalties received in the prior year. System revenue for","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1289340/000149315223015876/0001493152-23-015876-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$6.5 million"},{"label":"Net income","value":"($5.3) million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}